Latest News

Monoclonal Antibody LY3475766 Safely Lowers Atherogenic Lipids in Phase 1 Trial
Written by: Radcliffe Cardiology
Monoclonal Antibody LY3475766 Safely Lowers Atherogenic Lipids in Phase 1 Trial
Total ApoB and Lp(a) Count Deemed Superior for CAD Risk Assessment
Written by: Radcliffe CVRM
Total ApoB and Lp(a) Count Deemed Superior for CAD Risk Assessment
Semaglutide 2.4 mg Achieves 63% MASH Resolution in Phase 3 ESSENCE Trial
Written by: Radcliffe CVRM
Semaglutide 2.4mg Achieves 63% MASH Resolution in Phase 3 ESSENCE Trial
Written by: Radcliffe CVRM
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Offer Enhanced Kidney Protection, Especially in…
Study Finds Multimorbidity Dramatically Increases Mortality Risk in Heart Failure Patients with Mildly Reduced and Preserved Ejection Fraction
Written by: Radcliffe CVRM
Study Finds Multimorbidity Dramatically Increases Mortality Risk in Heart Failure Patients with Mildly…
Written by: Radcliffe CVRM
GLP-1 Receptor Agonists Reduce Risks of Dementia, Cardiovascular Disease, and Psychiatric Disorders:…
Liver Disease: Efruxifermin Showed 39% Cirrhosis Reversal in MASH Patients in the Phase 2b SYMMETRY Study
Written by: Radcliffe CVRM
Liver Disease: Efruxifermin Showed 39% Cirrhosis Reversal in MASH Patients in the Phase 2b SYMMETRY Study
Serum Uric Acid as an Independent Predictor of Non-Alcoholic Fatty Liver Disease in Non-Obese Young Adults
Written by: Radcliffe CVRM
Serum Uric Acid as an Independent Predictor of Non-Alcoholic Fatty Liver Disease in Non-Obese Young…
Late-Breaking Trail and Featured Clinical Research Presentations Revealed for ACC Scientific Sessions 2025
Written by: ACC 2025
Late-Breaking Trial and Featured Clinical Research Presentations Revealed for ACC Scientific Sessions…
BPROAD: Promising Results for Intensive Blood Pressure Control in Type 2 Diabetes Patients
Written by: Radcliffe CVRM
BPROAD: Promising Results for Intensive Blood Pressure Control in Type 2 Diabetes Patients

External news

Written by: Medscape
AI Predicts Heart Failure Risk From ‘Invisible’ Heart Fat
Written by: Cardiac Vascular News
ABK Biomedical and COR Development Partner to Establish Long-Term Commercial Manufacturing Facility in Ashland, Missouri
Written by: Cardiac Vascular News
DeepSight™ Technology Unveils its Comprehensive NeedleVue™ Platform at SIR 2026, Expanding the Future for Precision Ultrasound-Guided Interventions
Written by: Cardiovascular Business
New gene therapy may help protect the hearts of patients with Friedreich's ataxia
Written by: Medscape
New Central Sleep Apnea Guidelines: Did They Go Too Far?
Written by: Medscape
Weight Loss Stalled? Helping Patients Navigate Plateaus
Written by: Medscape
US FDA Warns Medline Over Defective Heart Procedure Syringes
Written by: Cardiac Vascular News
Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG
Written by: Cardiac Vascular News
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System
Written by: Cardiac Vascular News
AliveCor Expands AI-Powered 12-lead Cardiac Diagnostics to Vietnam, Advancing Access to Early Detection and Modernized Cardiac Care